Faruqi & Faruqi & Nasdaq-100
13 shared events · Importance 5 · Last updated May 09, 2026
Live sentiment trends, interaction importance charts, and action volume tracking available on the
NewsDesk Dashboard
Business
Faruqi & Faruqi: Faruqi & Faruqi is investigating potential claims against Gossamer Bio and reminds investors of the deadline to seek the role of lead plaintiff in a federal securities class action.
Nasdaq-100: Gossamer Bio has not met the minimum share bid price required for continued listing on the Nasdaq Global Select Market, indicating a potential delisting.
Apr 01, 2026 · 103 articles
Business
Faruqi & Faruqi: Faruqi & Faruqi is a national securities law firm investigating potential claims against Zynex and reminding investors of the deadline to seek lead plaintiff status in a federal securities class action.
Nasdaq-100: Zynex was delisted from the Nasdaq-100 following the revelations of its overbilling scheme and subsequent bankruptcy filing.
Feb 24, 2026 · 35 articles
Regulatory
Faruqi & Faruqi: Faruqi & Faruqi, a national securities law firm, is investigating potential claims against Regencell Bioscience Holdings and is encouraging investors to join the class action lawsuit.
Nasdaq-100: Regencell Bioscience Holdings' shares are traded on Nasdaq-100, which is the exchange where the volatility and subsequent price drop occurred.
May 03, 2026 · 6 articles
Business
Faruqi & Faruqi: Faruqi & Faruqi is a national securities law firm investigating potential claims against Gossamer Bio and reminding investors of the deadline to seek lead plaintiff status in the class action lawsuit.
Nasdaq-100: Gossamer Bio's stock is traded on Nasdaq-100, and its price plummeted following the adverse study results.
May 01, 2026 · 6 articles
Business
Faruqi & Faruqi: Faruqi & Faruqi, a national securities law firm, is investigating potential claims against New Era Energy & Digital and reminds investors of the lead plaintiff deadline.
Nasdaq-100: Nasdaq-100 is the stock exchange where New Era Energy & Digital securities are traded, making the company subject to federal securities laws.
Apr 02, 2026 · 82 articles
Business
Faruqi & Faruqi: Faruqi & Faruqi is investigating potential claims against MiNK Therapeutics and reminds investors of the lead plaintiff deadline in the federal securities class action.
Nasdaq-100: Nasdaq-100 is the stock exchange where MiNK Therapeutics' common stock is traded, providing the platform for the securities involved in the class action.
Apr 01, 2026 · 83 articles
Business
Faruqi & Faruqi: Faruqi & Faruqi is investigating potential claims against ODDITY Tech and reminds investors of the deadline to seek the role of lead plaintiff in the federal securities class action.
Nasdaq-100: Nasdaq-100 is the stock exchange where ODDITY Tech securities are traded.
Apr 01, 2026 · 93 articles
Business
Faruqi & Faruqi: Faruqi & Faruqi, a national securities law firm, is investigating potential claims against Firefly Aerospace Inc. and encouraging investors to join a class action lawsuit.
Nov 20, 2025 · 6 articles
Business
Nasdaq-100: Treace Medical Concepts is listed on Nasdaq-100, and its stock price fell significantly after the announcement of lowered revenue guidance.
May 16, 2025 · 6 articles
Business
Nasdaq-100: General Atomics, Inc. is listed on Nasdaq-100, and its stock price decline is noted in the context of the lawsuit.
May 14, 2025 · 6 articles
Regulatory
Nasdaq-100: Atara Biotherapeutics, Inc. is listed on Nasdaq-100, and its stock price decline is reported in relation to this exchange.
May 18, 2025 · 6 articles
NEWSDESK
Explore this relationship live
Track how Faruqi & Faruqi and Nasdaq-100 interact across events, view sentiment trends, and discover connected entities.
Open Dashboard